Matching Funds for Research Recommendation

TOTAL SCORE: 8

Score
A1 (Feasibility increased by continuance of pandemic): 0
A2 (Necessity increased by covid pandemic): +1
A3 (political viability): +1
B1 (Relevance to the specific goal of increasing HALE by 5 years by 2035): +1
B2 (Relevance to general goal of biomedical healthy life extension): +1
C1 (Market readiness applicability): 0
C2 (Project readiness): 0
C3 (Move to market readiness): +1
D1 (Actionability): 0
D2 (Degree of measurability): 0
D3 (Degree of leveraging cross-sector inputs): +1
D4 (Awareness of international context): 0
D5 (Resourcefulness): +1
D6 (Reorganisation): 0
E (Disruptiveness): +1
F (Dividends - does the recommendation aid in social activity and inclusivity?): 0

Point of comparison: The Committee’s document correctly identifies the shortcomings of UK funding, but must explore more thoroughly lessons from other countries, not only countries with superior HALE to the UK, but also similar-sized democracies.

RECOMMENDATION SUMMARY

Adopt the Australian policy of matching motor neuron disease research dollar for dollar but for relevant aging research.
Industry: Tier 3 Recommendations
Register and Claim Ownership